# Management of Pruritus With Xyzal in Atopic Dermatitis

> **NCT00884325** · PHASE4 · COMPLETED · sponsor: **Derm Research, PLLC** · enrollment: 40 (actual)

## Conditions studied

- Atopic Dermatitis
- Pruritus

## Interventions

- **DRUG:** Levocetirizine dihydrochloride (Xyzal)
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT00884325
- **Lead sponsor:** Derm Research, PLLC
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-02
- **Primary completion:** 2010-01
- **Final completion:** 2010-01
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2013-08-16

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00884325

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00884325, "Management of Pruritus With Xyzal in Atopic Dermatitis". Retrieved via AI Analytics 2026-07-11 from https://api.ai-analytics.org/clinical/NCT00884325. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*